AstraZeneca experiences significant sales growth due to introduction of new drugs
The pharmaceutical manufacturer, AstraZeneca, has seen considerable sales growth due to the increased demand in its new drugs during the third quarter, Reuters reports.
With sales rising 8% in constant currencies, shares in the group increased 2% in early trading on Thursday (8 November).
Since 2012, AstraZeneca has experienced a significant reduction in patents on older drugs, however, with the implantation of 10 new medicines, has seen a growth of 85% during the last quarter.
- Nissan signs MoU to build assembly plant in Ghana
- Hyundai and Kia to invest combined $250mn in Grab to increase EV implementation
- BASF Venture Capital GmBH to invest in 3D printing firm Prismlab
- Read the latest issue of Manufacturing Global here!
The medicines include Imfinzi and Tagrisso which can be used for lung cancer, Fasenra to treat severe asthma and Lynparza for ovarian cancer.
The firm also hopes for success for Farxiga, which can be used to help diabetes and reduce heart risks with the drugmaker predicting years of continued improvement for its medicines.
China has seen a 32% increase in the quarter with AstraZeneca continuing to beat competitors in the world’s second biggest drugs market.
Chief Executive, Pascal Soriot, said: “Today marks an important day for the future of AstraZeneca, with the performance in the quarter and year to date showing what we expect will be the start of a period of sustained growth for years to come.”
Fluent.ai x BSH: Voice Automating the Assembly Line
Coming soon, Fluent.ai will deploy its voice recognition solutions in one of BSH’s German factories. BSH leads the market in producing connected appliances—its brands include Bosch, Siemens, Gaggenau, NEFF, and Thermador, and with this new partnership, the company intends to cut transition time in its assembly lines.
According to BSH, voice automation will yield 75%-100% efficiency gains—but it’s the collaboration between the two companies that stands out. ‘After considering 11 companies for this partnership, we chose Fluent.ai because of their key competitive differentiators’, explained Ion Hauer, Venture Partner at BSH Startup Kitchen.
What Sets Fluent.ai Apart?
After seven years of research, the company developed a wide range of artificial intelligence (AI) software products to help original equipment manufacturers (OEM) expand their services. Three key aspects stood out to BSH, which operates across the world and in unique factory environments.
- Robust noise controls. The system can operate even in loud conditions.
- Low latency. The AI understands commands quickly and accurately.
- Multilingual support. BSH can expand the automation to any of its 50+ country operations.
How Voice Automation Works
Instead of pressing buttons, BSH factory workers will now be able to speak into a headset fitted with Fluent.ai’s voice recognition technology. After uttering a WakeWord, workers can use a command to start assembly line movement. As the technology is hands-free, workers benefit from less physical strain, which will both reduce employee fatigue and boost line production.
‘Implementing Fluent’s technology has already improved efficiencies within our factory, with initial implementation of the solution cutting down the transition time from four seconds to one and a half”, said Markus Maier, Project Lead at the BSH factory. ‘In the long run, the production time savings will be invaluable’.
Future Global Adoption
In the coming years, BSH and Fluent.ai will continue to push for artificial intelligence on factory lines, pursuing efficiency, ergonomics, and a healthy work environment. ‘We started with Fluent.ai on one factory assembly line, moved to three, and [are now] considering rolling the technology out worldwide’, said Maier.
Said Probal Lala, Fluent.ai’s CEO: ‘We are thrilled to be working with BSH, a company at the forefront of innovation. Seeing your solution out in the real world is incredibly rewarding, and we look forward to continuing and growing our collaboration’.